EUVIMEDEUVIMED entdecken
Multizentrische Studie

Surgical management of small bowel adenocarcinoma in Crohn disease: a multicenter retrospective analysis

Tommaso Violante iD, Davide Ferrari, Matteo Rottoli iD, Marco Novelli, David W Larson, Sara A Aboelmaaty, Ibrahim Gomaa, Richard Sassun iD, Annaclara Sileo iD, Sherief S Shawki, Anjelli Wignakumar, Justin Dourado und 10 weitere

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izaf312 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Tommaso Violante und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Crohn Disease, Adenocarcinoma, Intestinal Neoplasms, Intestine, Small. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with Crohn disease (CD) face an elevated risk of developing small bowel adenocarcinoma (SBA), a malignancy characterized by late-stage diagnosis and poor prognosis. In this study we aimed to characterize surgical management and oncologic outcomes for CD-associated SBA.

Methods

A retrospective review was conducted across 3 tertiary IBD centers, analyzing 99 patients with CD who underwent surgery for SBA between 1992 and 2025. Data included patient demographics, CD history, surgical details, and oncologic outcomes.

Results

The median time from CD diagnosis to SBA was 25 years. The SBA diagnosis was incidental in 74.8% of cases, discovered during surgery for other complications. Tumors were predominantly located in the ileum (80.8%) and showed aggressive features: 56.6% were poorly differentiated (grade 3), and 85.9% were pathologically advanced (T3/T4 on TNM staging). Nodal involvement was present in 45.5% of patients, and 18.2% had distant metastases at diagnosis. A complete (R0) resection was achieved in 90.9% of surgeries, with a 30-day morbidity rate of 26.3%. After a median follow-up of 36 months, the distant recurrence rate was 28.3%, and overall mortality was 27.3% (18.2% cancer related).

Conclusion

In patients with long-standing CD, SBA is typically an incidental diagnosis made at an advanced stage. While high rates of complete surgical resection are possible, the prognosis remains guarded due to aggressive tumor biology and high recurrence rates. These findings highlight a critical need for improved risk stratification to guide surveillance and for the development of evidence-based adjuvant treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseAdenocarcinomaIntestinal NeoplasmsIntestine, SmallIleal NeoplasmsHumansRetrospective StudiesMaleFemaleAdultMiddle AgedYoung AdultPrognosisFollow-Up StudiesAgedNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Crohn diseasesmall bowel adenocarcinomasurgical outcomes

Autor:innen und Institutionen

  • Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, United States.
  • Department of Surgery, Orsi Academy, Melle, Belgium.
  • Department of Surgery, Istituto Nazionale dei Tumori, Milan, Italy.
  • Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
  • Department of Statistics, Alma Mater Studiorum-University of Bologna, Bologna, Italy.

ORCID-Profile: Tommaso Violante, Matteo Rottoli, Richard Sassun, Annaclara Sileo, Stefan Holubar, Ali Alipouriani, Kellie L Mathis

Zitieren

APA

Violante, T., Ferrari, D., Rottoli, M., Novelli, M., Larson, D. W., Aboelmaaty, S. A., Gomaa, I., Sassun, R., Sileo, A., Shawki, S. S., Wignakumar, A., Dourado, J., Syed, A., Wexner, S., Calini, G., Castagna, G., Greco, N. M., Isopi, C., Holubar, S., …, & Mathis, K. L. (2025). Surgical management of small bowel adenocarcinoma in Crohn disease: a multicenter retrospective analysis. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf312

Vancouver

Violante T, Ferrari D, Rottoli M, Novelli M, Larson DW, Aboelmaaty SA, et al. Surgical management of small bowel adenocarcinoma in Crohn disease: a multicenter retrospective analysis. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf312

BibTeX
@article{Violante2025,
  author = {Violante, Tommaso and Ferrari, Davide and Rottoli, Matteo and Novelli, Marco and Larson, David W and Aboelmaaty, Sara A and Gomaa, Ibrahim and Sassun, Richard and Sileo, Annaclara and Shawki, Sherief S and Wignakumar, Anjelli and Dourado, Justin and Syed, Ajia and Wexner, Steven and Calini, Giacomo and Castagna, Giovanni and Greco, Nicola Maria and Isopi, Claudio and Holubar, Stefan and Alipouriani, Ali and Unal, Ece and Mathis, Kellie L},
  title = {Surgical management of small bowel adenocarcinoma in Crohn disease: a multicenter retrospective analysis},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izaf312}
}
Kostenlos starten →